This metabolic change not only hinders CD8+ T cells’ ability to function normally by depriving them of vital glucose, but the accumulated lactate can also further disrupt CD8+ T cells’ TCA cycle by inhibiting pyruvate carboxylase (PC), which reduces their anti-tumor activity (118, 119). The gene discussed is CD8A; the disease is neoplasm.